"The changing paradigm": TAVR for low-risk patients approved by the FDA
- PMID: 31765011
- DOI: 10.1111/jocs.14336
"The changing paradigm": TAVR for low-risk patients approved by the FDA
Keywords: FDA; LOW RISK; SAVR; TAVR; TRIAL.
References
REFERENCES
-
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
-
- Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
-
- Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972-1981.
-
- Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-1798.
-
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-1705.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
